We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Acute Kidney Injury With Buffered Crystalloids vs Saline Among ICU Patients

Fu S. Xue, MD1; Rui P. Li, MD1; Chao Sun, MD1
[+] Author Affiliations
1Chinese Academy of Medical Sciences, Beijing, People’s Republic of China
JAMA. 2016;315(14):1518-1519. doi:10.1001/jama.2016.0151.
Text Size: A A A
Published online


To the Editor In the study by Dr Young and colleagues1 comparing kidney toxicity of a buffered crystalloid solution vs saline in patients admitted to the intensive care unit (ICU), acute kidney injury (AKI) was defined based solely on the serum creatinine criteria of the risk, injury, failure, loss, and end-stage renal failure (RIFLE) classification. The mean volumes of intravenous study and nonstudy fluids administered in 24 hours prior to enrollment and during the observation period were not significantly different between groups, but the ranges were variable. We would like to know whether the serum creatinine levels used for diagnosis of AKI in this study were adjusted for the fluid balance of patients. It has been shown that not adjusting serum creatinine levels for fluid balance in patients who are critically ill may underestimate the severity of AKI, whereas adjusting serum creatinine levels for fluid balance can improve recognition and staging of AKI.2,3


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




April 12, 2016
Paul Young, FCICM; Michael Bailey, PhD; Rinaldo Bellomo, FCICM
1Medical Research Institute of New Zealand, Wellington, New Zealand
2Australian and New Zealand Intensive Care Research Center, Monash University, Melbourne, Victoria, Australia
3Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia
JAMA. 2016;315(14):1521. doi:10.1001/jama.2016.0157.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...